In a filing, Vanda Pharmaceuticals Inc revealed its President and CEO Polymeropoulos Mihael Hristos acquired Company’s shares for reported $50150.0 on Mar 06 ’25. In the deal valued at $5.01 per share,10,000 shares were bought. As a result of this transaction, Polymeropoulos Mihael Hristos now holds 2,295,731 shares worth roughly $11.43 million.
Then, Polymeropoulos Mihael Hristos bought 10,000 shares, generating $50,200 in total proceeds. Upon buying the shares at $5.02, the President and CEO now owns 2,285,731 shares.
Before that, Polymeropoulos Mihael Hristos bought 10,000 shares. Vanda Pharmaceuticals Inc shares valued at $47,050 were divested by the President and CEO at a price of $4.71 per share. As a result of the transaction, Polymeropoulos Mihael Hristos now holds 2,275,731 shares, worth roughly $11.33 million.
H.C. Wainwright initiated its Vanda Pharmaceuticals Inc [VNDA] rating to a Buy in a research note published on October 31, 2024; the price target was $18. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in mid July with a ‘”an Overweight”‘ rating. Jefferies also remained covering VNDA and has decreased its forecast on February 25, 2022 with a “Hold” recommendation from previously “Buy” rating. BofA Securities started covering the stock on May 12, 2021. It rated VNDA as “a Buy”.
Price Performance Review of VNDA
On Friday, Vanda Pharmaceuticals Inc [NASDAQ:VNDA] saw its stock jump 1.22% to $4.98. Over the last five days, the stock has gained 2.68%. Vanda Pharmaceuticals Inc shares have risen nearly 3.97% since the year began. Nevertheless, the stocks have risen 28.35% over the past one year. While a 52-week high of $6.75 was reached on 03/06/25, a 52-week low of $3.71 was recorded on 02/14/25. SMA at 50 days reached $4.63, while 200 days put it at $5.05.
Levels Of Support And Resistance For VNDA Stock
The 24-hour chart illustrates a support level at 4.90, which if violated will result in even more drops to 4.83. On the upside, there is a resistance level at 5.06. A further resistance level may holdings at 5.14. The Relative Strength Index (RSI) on the 14-day chart is 58.23, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.12, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 23.60%. Stochastics %K at 73.03% indicates the stock is a holding.
How much short interest is there in Vanda Pharmaceuticals Inc?
A steep rise in short interest was recorded in Vanda Pharmaceuticals Inc stocks on 2025-02-28, dropping by -0.47 million shares to a total of 3.28 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 3.74 million shares. There was a decline of -14.2%, which implies that there is a negative sentiment for the stock.
